Scribd
Upload
48 views2 pages

My Tommorows

Uploaded by

michal.altgo
Copyright
© © All Rights Reserved
We take content rights seriously. If you suspect this is your content, claim it here.
Available Formats
Download as PDF, TXT or read online on Scribd
48 views2 pages

My Tommorows

Uploaded by

michal.altgo
Copyright
© © All Rights Reserved
We take content rights seriously. If you suspect this is your content, claim it here.
Available Formats
Download as PDF, TXT or read online on Scribd
You are on page 1/ 2

2024 BIO Convention Company Profile - Exported on May 29 2024

Brief description
myTomorrows is a global HealthTech company helping patients discover and access treatment options. We partner with
BioPharma to enhance patient recruitment for clinical trials, support expanded access programs, and gather invaluable real-
world data.

Description
myTomorrows is a global healthtech company dedicated to breaking down barriers for patients seeking treatment options.
MYTOMORROWS Through our advanced digital platform, we help physicians and patients discover and access treatment options.
myTomorrows partners with BioPharma companies to: • Enhance patient recruitment for clinical trials • Provide market
United States
CMO, CRO,Other R&D services,Digital health access via global expanded access programs • Gather invaluable real-world data We integrate advanced technology with
FINANCIALS personalized support for effective operations. With over a decade of expertise, myTomorrows has developed partnerships
with more than 50 BioPharma companies with assets from Phase 2 through commercialization and helped patients in 195+
Employees 50 to 200
Year Founded 2012 countries.

CONTACT
 https://www.mytomorrows.com/
Delegates

Laura Cox
Director, Partnership
Development

Services
Clinical Trial Patient Recruitment
Utilizing our advanced digital platform, we partner with BioPharma to enhance patient recruitment for
clinical trials. We support clinical trial awareness, pre-screening, referrals & retention.

Page 1 of 2
2024 BIO Convention Company Profile - Exported on May 29 2024

Market access via global expanded access programs


We guide BioPharma companies through developing expanded access strategies up to full EAP execution and
preparation for full commercial launch. We have experience in a wide range of expanded access use cases,
across different regions and therapeutics areas: - Free-of-charge or paid-for - Single patient or cohort
programs - Post-trial access Conducting expanded access programs on behalf of our clients is our core
expertise. Our team of experts handles areas such as Regulatory, Quality, Site Management, Supply Chain,
Real-World Data, and Pharmacovigilance.

MYTOMORROWS
Real-World Data Collection within Expanded Access
United States
CMO, CRO,Other R&D services,Digital health
myTomorrows is a thought leader in collecting real-world data within an expanded access setting. Our
FINANCIALS dedicated real-world data team offers an integrated approach towards the strategy, collection and analysis of
Employees 50 to 200 data in non-interventional settings under Expanded Access pathways.
Year Founded 2012

CONTACT
 https://www.mytomorrows.com/

Page 2 of 2

You might also like